PPBT Purple Biotech Ltd. - American Depositary Shares
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 19, 2026
$1.51
· of 52w range
· above low
· to high
$0.4852w low
$5.6652w high
P/E
24.4
EPS
$0.03
your badges
52W Range
$0–$6
Analyst Rating
·
Price Target
$17
P/E
24.4
ROE
-124.0%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
PPBT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.51
P/E
24.4
EPS
$0.03
ROE
-124.0%
52W Range
$0–$6
PPBT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| March 2, 2026 | 1-for-10 | Reverse |
| Sept. 17, 2024 | 1-for-20 | Reverse |
| Aug. 21, 2020 | 1-for-10 | Reverse |
About Purple Biotech Ltd. - American Depositary Shares Company overview from Wikipedia
sectorHealthcare
industryPharmaceuticals
employees10
countryIL
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2017-12-31 → 2020-12-31
EPS$0.032021-12-31 → 2025-12-31
Free Cash Flow$-6M2019-12-31 → 2025-12-31
Net margin·2019-12-31 → 2020-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | PPBT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | 24.45Y avg ≈8.5 | ≈8.5 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | PPBT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -96.6%5Y avg ≈-3.1% | ≈-3.1% | -60.8% | Weak | |
| ROE | -124.0%5Y avg ≈-6.4% | ≈-6.4% | -96.9% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | PPBT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 1.35Y avg ≈2.6 | ≈2.6 | 1.8 | Low liquidity | |
| Quick Ratio | 1.15Y avg ≈0.3 | ≈0.3 | 0.8 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| March 31, 2025 | $-0.17 | — | — | |
| Dec. 31, 2023 | $-0.32 | — | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $1M | $1M | $1M | |
| R&D Expense | $4M | $8M | $17M | $16M | $12M | $7M | $2M | $5M | |
| SG&A Expense | $3M | $3M | $5M | $6M | $6M | $6M | $4M | $5M | |
| Operating Income | · | · | $-22M | $-23M | $-18M | $-13M | $-7M | $-8M | |
| Interest Expense | $982.0K | $483.0K | $2M | $67.0K | $-212.0K | $61.0K | $181.0K | $576.0K | |
| Interest Income | $424.0K | $868.0K | $992.0K | $910.0K | $-320.0K | $254.0K | $151.0K | $93.0K | |
| Income Tax | · | · | · | · | · | · | $216.0K | · | |
| Net Income | $-26M | $-7M | $-20M | $-22M | $18M | $28M | $6M | $5M | |
| EPS (Basic) | $0.03 | · | · | $23.97 | $17568036.00 | · | · | · | |
| EPS (Diluted) | $0.03 | · | · | $23.97 | $17568036.00 | · | · | · | |
| Shares (Basic) | 960,106,739 | · | · | 904,054 | 17,568,036 | 11,500,113 | 19,367,484 | 14,205,301 | |
| Shares (Diluted) | 480,053 | · | · | 904,054 | · | · | · | · | |
| EBITDA | · | · | $-22M | · | · | $-13M | $-7M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $7M | $14M | $15M | $69.0K | $11M | $4M | $5M | |
| Current Assets | $10M | $9M | $16M | $33M | $48M | $59M | $8M | $9M | |
| PP&E (Net) | $124.0K | $124.0K | $154.0K | $215.0K | $277.0K | $178.0K | $38.0K | $37.0K | |
| Intangibles | $7M | $28M | $28M | $21M | $20M | $20M | $6M | $6M | |
| Total Assets | $18M | $37M | $44M | $55M | $70M | $84M | $15M | $15M | |
| Current Liabilities | $8M | $4M | $10M | $7M | $4M | $3M | $4M | $3M | |
| Retained Earnings | $-171M | $-145M | $-137M | $-118M | $-96M | $-78M | $-50M | $-44M | |
| Stockholders' Equity | $10M | $33M | $34M | $47M | $65M | $79M | $10M | $11M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | · | · | · | $1M | $1M | $657.0K | · | |
| Operating Cash Flow | $-6M | $-14M | $-20M | $-17M | $-374.0K | $2M | $-2M | $-8M | |
| CapEx | $3.0K | · | $3.0K | $26.0K | $115.0K | $156.0K | $11.0K | $16.0K | |
| Investing Cash Flow | $632.0K | $509.0K | $14M | $20M | $13M | $-50M | $-449.0K | $2M | |
| Financing Cash Flow | $6M | $7M | $5M | $1M | · | · | · | $8M | |
| Free Cash Flow | $-6M | · | · | · | $-489.0K | $-12M | $-6M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -1261.2% | -715.6% | · | |
| Net Margin | · | · | · | · | · | 2799.9% | 585.0% | · | |
| EBITDA Margin | · | · | · | · | · | -1261.2% | -715.6% | · | |
| ROA | -96.6% | -17.8% | 40.2% | 34.7% | 23.9% | 56.8% | 39.7% | · | |
| ROE | -124.0% | -21.6% | 49.0% | 38.8% | 25.5% | 62.4% | 55.9% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 2.2 | 2.2 | 4.7 | · | 19.1 | 2.3 | · | |
| Quick Ratio | 1.1 | 0.0 | 0.0 | · | 0.0 | 3.6 | 1.2 | · | |
| Interest Coverage | · | · | 10.1 | · | · | -206.8 | -39.5 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | 0.1 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash Flow / Share | $-11.78 | $-8.76 | · | · | · | · | · | · | |
| EPS (TTM) | $0.03 | · | · | $23.97 | $17568036.00 | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | $1M | $1M | · | |
| Net Income TTM | $-26M | $-7M | $-20M | $-22M | $18M | $28M | $6M | · | |
| P/E | 24.4 | · | · | 1.2 | 0.0 | · | · | · | |
| Earnings Yield | 4.1% | · | · | 86.9% | 22581023.1% | · | · | · |
Valuation (TTM)
| Metric | Trend | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | $100.0K | · | · | |
| Net Income TTM | $6M | $5M | $12M | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-26M | $-7M | $-20M | $-22M | $18M |
| Diluted EPS | $0.03 | · | · | $23.97 | $17568036.00 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 1.3 | 2.2 | 2.2 | 4.7 | · |
| Quick Ratio | 1.1 | 0.0 | 0.0 | · | 0.0 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-6M | · | · | · | $-489.0K |
Institutional owners (13F) 1 filer · $10K total · As of Dec. 31, 2025
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
1
Value held
$10K
New positions
8
Exited positions
3
Institutional activity — Q4 2025 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 8 (+5 vs prior Q) | 3 (+1 vs prior Q) | 5 (0 vs prior Q) | 3 (+2 vs prior Q) | +708K |
Compared to Q3 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| TWO SIGMA ADVISERS, LP | $9,665 | 14,700 | 100.00% | Shares |
PPBT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
1 analysts · 2026-10-03Mean target $17.00 +1025.8%
Low$17.00
Mean$17.00
High$17.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 19, 2026